Ergoteles LLC Bristol Myers Squibb CO Transaction History

Ergoteles LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $972 - $575,070	-7,484 Reduced 18.97%	31,964 $2.27 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $878,992 - $968,077	12,104 Added 44.27%	39,448 $3.04 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $1.68 Million - $2.02 Million	27,344 New	27,344 $2 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $971,561 - $1.13 Million	-18,116 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $15 Million - $17.6 Million	-253,920 Reduced 93.34%	18,116 $1.07 Million
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $4.97 Million - $5.41 Million	-80,309 Reduced 22.79%	272,036 $18.2 Million
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $18.2 Million - $20.4 Million	306,318 Added 665.52%	352,345 $22.2 Million
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $974,247 - $1.1 Million	-16,873 Reduced 26.83%	46,027 $2.86 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $3.61 Million - $4 Million	62,900 New	62,900 $3.79 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.